InsiderTrades

Form 4 for ALAB Astera Labs, Inc.

Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-11 · accession 0001736297-24-000048 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-11-13 2024-11-11 ALAB Mohan Jitendra CEO, Dir S - Sale $100.01 -2,302 4.50M -0.1% -$230.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-11 S D 387 $100.01 907,401 I By Trust — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F8) These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2 Common Common Stock 2024-11-11 S D 383 $100.01 657,406 I By 2022 Trust 2 — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F7) These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3 Common Common Stock 2024-11-11 S D 383 $100.01 657,406 I By 2022 Trust 1 — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F6) These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4 Common Common Stock 2024-11-11 S D 383 $100.01 907,406 I By 2021 Trust 2 — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F5) These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
5 Common Common Stock 2024-11-11 S D 383 $100.01 907,405 I By 2021 Trust 1 — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F4) These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
6 Common Common Stock 2024-11-11 S D 383 $100.01 4,500,009 I By Living Trust — — (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. (F3) These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.